XORTX Therapeutics Inc. Stock Analysis & AI Score
XORTX Therapeutics Inc. (XRTX) has an ST Score of 42.5 (C), driven by its Growth (A+) and held back by its Profitability (D). XRTX last traded at $1.72.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
XORTX Therapeutics Inc. (XRTX) has an ST Score of 42.5 (C), driven by its Growth (A+) and held back by its Profitability (D). XRTX last traded at $1.72.
- Strongest
- GrowthA+
- Weakest
- ProfitabilityD
All factor grades
- GrowthA+
- ValuationB-
- Financial StrengthC+
- MomentumD+
- ProfitabilityD
- Piotroski1/9
Contact
XRTX stock: frequently asked questions
What is XRTX's ST Score?
XORTX Therapeutics Inc. (XRTX) has an ST Score of 42.5 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is XRTX a buy, hold, or sell?
Our ST Score grades it C (42.5/100). The ST Score is a data-driven signal, not a recommendation.
What are XRTX's factor grades?
Valuation B-, Profitability D, Financial Strength C+, Momentum D+, Growth A+.
What is XRTX's valuation grade?
XORTX Therapeutics Inc. (XRTX) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is XRTX's growth grade?
XORTX Therapeutics Inc. (XRTX) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is XRTX's profitability grade?
XORTX Therapeutics Inc. (XRTX) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is XRTX's financial strength grade?
XORTX Therapeutics Inc. (XRTX) earns a financial strength grade of C+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is XRTX's Piotroski score?
XORTX Therapeutics Inc. (XRTX) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.